Integrating omics technologies to study pulmonary physiology and pathology at the systems level

Cellular Physiology and Biochemistry

Volumn 33, Issue 5, 2014, Pages 1239-1260

  Pathak, Ravi Ramesh ^a   Davé, Vrushank ^a  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

ChIP Seq; Diseasosomes; Epigenomics; Genomics; Interactomes; Network Biology; Proteomics; RNA Seq; Systems Biology; Transcriptomes

Indexed keywords

PROTEOME;

EPIGENETICS; GENOME; GENOMICS; LUNG; LUNG DISEASE; METABOLOME; METABOLOMICS; ORGAN SYSTEMS; PATHOGENESIS; PATHOLOGY; PRIORITY JOURNAL; PROTEOMICS; REVIEW; RNA SEQUENCE; SCIENTIST; BIOLOGICAL ACTIVITY; DISEASE COURSE; GENETICS; HUMAN; LUNG FUNCTION; PHYSIOLOGY; PULMONARY PATHOLOGY; PULMONARY PHYSIOLOGY; SYSTEMS BIOLOGY; METABOLISM; PATHOPHYSIOLOGY;

GENOMICS; HUMANS; LUNG; LUNG DISEASES; METABOLOMICS; PROTEOMICS;

EID: 84899591828     PISSN: 10158987     EISSN: 14219778     Source Type: Journal    
DOI: 10.1159/000358693     Document Type: Review

References (216)

1. Lander ES, Linton LM, Birren B, Nusbaum C, Zody MC, Baldwin J, Devon K, Dewar K, Doyle M, FitzHugh W, Funke R, Gage D, Harris K, Heaford A, et al.: Initial sequencing and analysis of the human genome. Nature 2001;409:860-921. (Pubitemid 32165345)
2. Venter JC, Adams MD, Myers EW, Li PW, Mural RJ, Sutton GG, Smith HO, Yandell M, Evans CA, Holt RA, Gocayne JD, Amanatides P, Ballew RM, Huson DH, et al.: The sequence of the human genome. Science 2001;291:1304-1351. (Pubitemid 32173090)
3. Ideker T, Galitski T, Hood L: A new approach to decoding life: Systems biology. Annu Rev Genomics Hum Genet 2001;2:343-372. (Pubitemid 35265011)
4. Kitano H: Systems biology: A brief overview. Science 2002;295:1662-1664. (Pubitemid 34202893)
5. Aderem A: Systems biology: Its practice and challenges. Cell 2005;121:511-513. (Pubitemid 40720005)
6. Kirschner MW: The meaning of systems biology. Cell 2005;121:503-504. (Pubitemid 40720002)
7. Chuang HY, Hofree M, Ideker T: A decade of systems biology. Annu Rev Cell Dev Biol 2010;26:721-744.
8. Sheppard D: Aspen lung conference 2010: Systems biology oflung diseases-progress in the omics era. Proc Am Thorac Soc 2011;8:199-202.
9. Auffray C, Adcock IM, Chung KF, Djukanovic R, Pison C, Sterk PJ: An integrative systems biology approach to understanding pulmonary diseases. Chest 2010;137:1410-1416.
10. Kaminsky DA, Irvin CG, Sterk PJ: Complex systems in pulmonary medicine: A systems biology approach to lung disease. J Appl Physiol 2011;110:1716-1722.
11. Wu W, Kaminski N: Chronic lung diseases. Wileylnterdiscip RevSyst Biol Med 2009;1:298-308.
12. Gosselink JV, Hayashi S, Elliott WM, Xing L, Chan B, Yang L, Wright C, Sin D, Pare PD, Pierce JA, Pierce RA, Patterson A, Cooper J, Hogg JC: Differential expression of tissue repair genes in the pathogenesis of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2010;181:1329-1335.
13. Patel NM, Kawut SM, Jelic S, Arcasoy SM, Lederer DJ, Borczuk AC: Pulmonary art eriole gene expression signature in idiopathic pulmonary fibrosis. Eur Respir J 2013;41:1324-1330.
14. Mura M, Anraku M, Yun Z, McRae K, Liu M, Waddell TK, Singer LG, Granton JT, Keshavjee S, De Perrot M: Gene expression profiling in the lungs of patients with pulmonary hypertension associated with pulmonary fibrosis. Chest 2012;141:661-673.
15. Drake JI, Gomez-Arroyo J, Dumur Cl, Kraskauskas D, Natarajan R, Bogaard HJ, Fawcett P, Voelkel NF: Chronic carvedilol treatment partially reverses the right ventricular failure transcriptional profile in experimental pulmonaryhypertension. Physiol Genomics 2013;45:449-461.
16. Wang XQ, Wang XM, Zhou TF, Dong LQ: Screening of differentially expressed gen es and small molecule drugs of pediatric allergic asthma with DNA microarray. Eur Rev Med Pharmacol Sci 2012;16:1961-1966.
17. Mariani TJ Martinez F Chronic obstructive pulmonary disease genomics: Yesterday, discovering population biomarkers; tomorrow, defining disease clusters Am JRespir Crit Care Med 2013 187 900-902
18. Mali P, Yang L, Esvelt KM, Aach J, Guell M, DiCarlo JE, Norville JE, Church GM: Rna-guided human genome engineeringvia cas9. Science 2013;339:823-826.
19. Spira A, Beane J, Shah V, Liu G, Schembri F, YangX, Palma J, BrodyJS: Effects of cigarette smoke onthe human ai rway epithelial cell transcriptome. Proc Natl Acad Sci USA 2004;101:10143-10148. (Pubitemid 38891209)
20. Beane J, Sebastiani P, Liu G, Brody JS, Lenburg ME, Spira A: Reversible and permanent effects of tobacco smoke ex posure on airway epithelial gene expression. Genome Biology 2007;8:R201.
21. ZhangX, Sebastiani P, Liu G, Schembri F, Dumas YM, Langer EM, Alekseyev Y, O'Connor GT, Brooks DR, Lenburg ME, Spira A: Similarities and differences between smoking-related gene expression in nasal and bronchial epithelium. Physiol Genomics 2010;41:1-8.
22. Spira A, Beane JE, Shah V, Steiling K, Liu G, Sch embri F, Gilman S, Dumas YM, Calner P, Sebastiani P, Sridhar S, Beamis J, Lamb C, Anderson T, Gerry N, Keane J, Lenburg ME, BrodyJS: Airway epithelial gene expression inthe diagnostic evaluation of smokers with suspect lung cancer. Nat Med 2007;13:361-366. (Pubitemid 46376687)
23. Beane J, Sebastiani P, Whitfield TH, Steiling K, Dumas YM, Lenburg ME, Spira A: A prediction model for lung cancer diagnosis that integrates genomic and clinical features. Cancer Prev Res (Phila) 2008;1:56-64.
24. Blaauboer ME, Emson CL, Verschuren L, Van Erk M, Turner SM, Everts V, Hanemaaijer R, Stoop R: Novel combination of collag en dynamics analysis and transcriptional profiling reveals fibrosis-relevant genes and pathways. Matrix Biology2013;32:424-431.
25. Lee TH, McKleroy W, Khalifeh-SoltaniA, Sakuma S, Lazarev S, Riento K, Nishimura SL, Nichols BJ, Atabai K: Functional genomic screen identifies novel mediators of collagen uptake. Molecular biology of the cell 2014 25
26. Frank JA, Erie DJ: Progress toward a systems biology approach to acute lung injury. Am J Physiol Lun g Cell Mol Physiol 2007;293:L290-291.
27. ChenY, Shi JX, PanXF, Feng J, Zhao H: DNA microarray-based screening of differentially expressed genes related to acute lung injury and functional analysis. Eur Rev Med Pharmac ol Sci 2013;17:1044-1050.
28. Singhal S, Miller D, Ramalingam S, Sun SY: Gene expression profiling of non-small cell lung cancer. Lung Cancer 2008;60:313-324.
29. Botling J, Edlund K, Lohr M, Hellwig B, Holmberg L, Lambe M, Berglund A, Ekman S, Bergqvist M, Ponten F, Konig A, Fernandes 0, Karlsson M, Helenius G, Karlsson C, Rahnenfuhrer J, Hengstler JG, Micke P: Biomarker discovery in non-small cell lung cancer: Integrating gene expression profiling, meta-analysis, and tissue microarray validation. Clin Cancer Res 2013;19:194-204.
30. Bourboulia D, Han H, Jensen-Taubman S, Gavil N, Isaac B, Wei B, Neckers L, Stetler-StevensonWG: Timp-2 modulates cancer cell transcriptional profile and enhances e-cadherin/beta-catenin complex expression in a549 lung cancer cells. Oncotarget 2013;4: 166-176.
31. LuC, Xiong M, Luo Y, Li J, Zhang Y, Dong Y, Zhu Y, Niu T, Wang Z, Duan L: Genome-wide transcriptional analysis of apoptosis-related genes and pathways regulated by h2ax in lung cancer a549 cells. Apoptosis 2013;18:1039-1047.
32. Herazo-Maya JD, Kaminski N: Evolving genomics of pulmonary fibrosis. Idiopathic Pulmonary Fibrosis 2014:379-402.
33. HardyJ, Singleton A: Genomew ide association studies and human disease. N Engl J Med 2009;360:1759-1768.
34. Turner AM: Fifty years on: Gwas confirms the role of a rare variant in lung disease. PLoS Genetics 2013;9:el003768.
35. Duan QL, Gaume BR, Hawkins GA, Himes BE, Bleecker ER, Klanderman B, Irvin CG, Peters SP, Meyers DA, Hanrahan JP, Lima JJ, Litonjua AA, Tantisira KG, Liggett SB: Regulatory haplotypes in ar gl are associated with altered bronchodilator response. Am J Respir Crit Care Med 2011;183:449-454.
36. Moffatt MF, Gut IG, Demenais F, Strachan DP, Bouzigon E, Heath S, Von Mutius E, Farrall M, Lathrop M, CooksonWO: Alarge-scale, consortium-based genomewide association study of asthma. N Engl J Med 2010;363:1211-1221.
37. Wu AC, Himes BE, Lasky-Su J, Litonjua A, Li L, Lange C, Li ma J, Irvin CG, Weiss ST: Development of a pharmacogenetic predictive test in asthma: Proof of concept. Pharmacogenet Genomics 2010;20:86-93.
38. Huang da W, Sherman BT, Lempicki RA: Systematic and integrative analysis of large gene lists using david bioinformatics resources. Nat Protoc 2009;4:44-57.
39. Huang da W Sherman BT Lempicki RA: Bioinformatics enrichment tools: Paths toward the comprehensive functional analysis oflarge gene lists. Nucleic Acids Res 2009;37:1-13.
40. Reich M, Liefeld T, Gould J, Lerner J, Tamayo P, Mesirov JP: Genepattern 2.0. Nat Genet 2006;38:500-501.
41. Goecks J, Nekrutenko A, TaylorJ: Galaxy: A comprehensive approach for supporting accessible, reproducible, and transparent computational research in the life sciences. Genome Biol 2010;11:R86.
42. Shannon P, Markiel A, Ozier 0, Baliga NS, Wang JT, Ramage D, Amin N, Schwikowski B, IdekerT: Cytoscape: A software environment for integrated models ofbiomolecular interaction networks. Genome Res 2003;13:2498-2504. (Pubitemid 37428274)
43. Edgar R, Domrachev M, Lash AE: Gene expression omnibus: Ncbi gene expression and hybridization array data repository. Nucleic Acids Res 2002;30:207-210. (Pubitemid 34679544)
44. Barrett T, Wilhite SE, Ledoux P, Evangelista C, Kim IF, Tomashevsky M, Marshall KA, Phillippy KH, Sherman PM, Holko M, Yefanov A, Lee H, Zhang N, Robertson CL, Serova N, Davis S, Soboleva A: Ncbi geo: Archive for functional genomi cs data sets-update. Nucleic Acids Res 2013;41:D991-995.
45. Rustici G, Kolesnikov N, Brandizi M, Burdett T, Dylag M, Emam I, Farne A, Hastings E, Ison J, Keays M, Kurbatova N, Malone J, Mani R, Mupo A, Pedro Pereira R, Pilicheva E, Rung J, Sharma A, Tang YA, Ternent T, Tikhonov A, Welter D, Williams E, Brazma A, Parkinson H, Sarkans U: Arrayexpress update-trends in database growth and links to data analysis tools. Nucleic Acids Res 2013;41:D987-990.
46. Sherlock G, Hernandez-Boussard T, Kasarskis A, Binkley G, Matese JC, Dwight SS, Kaloper M, Weng S, Jin H, Ball CA, Eisen MB, Spellman PT, Brown PO, Botstein D, Cherry JM: The Stanford microarray database. Nucleic Acids Res 2001;29:152-155. (Pubitemid 32054432)
47. Sirota M, Dudley JT, Kim J, ChiangAP, Morgan AA, Sweet-Cordero A, Sage J, Butte AJ: Discovery and preclinical validation of drug indications using compendia of public gene expression data. Science Trans Med2011;3:96ra77.
48. Nana-Sinkam SP, Hunter MG, Nuovo GJ, Schmittge n TD, Gelinas R, Galas D, Marsh CB: Integratingthe micrornome intothe studyoflungdisease.AmJ Resp Crit Care Med 2009;179:4-10.
49. Tomankova T, Petrek M, Kriegova E: Involvement of micrornas in physiological and pathological processes inthe lung. Respir Res 2010;11:159.
50. Zhou T, Garcia JGN, Zhang W: Integrating micrornas into a system biology approach to acute lung injury. Translat Res 2011;157:180-190.
51. Oglesby IK, McElvaney NG, Greene CM: Micrornas in inflammatory lung disease-master regulators or targetpractice Respir Res 2010;11:148.
52. Sayed D, Abdellatif M: Micrornas in developmentand disease. Physiol Rev 2011;91:827-887.
53. Pagdin T, Lavender P: Micrornas in lung diseases. Thorax 2012;67:183-184.
54. Sittka A, Schmeck B: M icrornas inthe lung. Adv Exp MedBiol 2013;774:121-134.
55. Sessa R, Hata A: Role of micrornas in lung development and pulmonary diseases. Pulmonary Circ 2013;3:315-328.
56. Pandit KV, Milosevic J, Kaminski N: Micrornas in idiopathic pulmonary fibrosis. Transl Res 2011;157:191-199.
57. Kass DJ, Kaminski N: Evolving genomic approaches to idiopathic pulmonary fibrosis: Moving beyond genes. Clin Transl Sci 2011;4:372-379.
58. Takahashi K, Yokota SI, Tatsumi N, Fukami T, Yok oi T, Nakajima M: Cigarette smoking substantially alters plasma microrna profiles in healthy subjects. Toxicol Appl Pharmacol 2013; 272:154-160.
59. Banerjee A, Luettich K: Micrornas as potential biomarkers of smoking-related diseases. Biomark Med 2012;6:671-684.
60. Graff JW, Powers LS, Dickson AM, Kim J, Reisetter AC, Hassan IH, Kremens K, Gross TJ, Wilson ME, Monick MM: Cigarette smoking decreases global microrna expression in human alveolar macrophages. PLoS One 2012;7:e44066.
61. Ellis KL CameronVA Troughton RW Frampton CM Ellmers LJ Richards AM; Circulating micrornas a s candidate markers to distinguish heartfailure in breathless patients. Eur J Heart Fail 2013;15; 1138-1147.
62. Donaldson A, Natanek SA, Lewis A, Man WD, Hopkinson NS, Polkey MI, Kemp PR: Incre ased skeletal muscle-specific microrna in the blood of patients with copd. Thorax 2013;68:1140-1149.
63. Madhavan D, Cuk K, Burwinkel B, Yang R: Cancer diagnosis and prognosis decoded by blood-based circulating microrna signatures. Front Genet 2013;4:116.
64. Rothschild SI: Epigenetic therapy in lung cancer-role of micrornas. Front Oncol 2013;3:158.
65. Tan Z, Randall G, Fan J, Camoretti-Mercado B, Brockman-Schneider R, Pan L, Solway J, Gern JE, Lemanske RF, Nicolae D, Ober C: Allele-specific targeting of micrornas to hla-g and risk of asthma. Am J Hum Genet 2007;81:829-834. (Pubitemid 47596550)
66. Shin JI, Brusselle GG: Mechanistic links between copd and lung cancer: A role of microrna let-7 Nat Rev Cancer 2014;14:70-70.
67. Jardim MJ, Dailey L, Silbajoris R, Diaz-Sanchez D: Distinct microrna expression in human airway cells of asthmatic donors identifies a novel asthma-associated gene. Am J Respir Cell Mol Biol 2012;47:536-542.
68. Solberg OD, Ostrin EJ, Love MI, Peng JC, Bha kta NR, Hou L, Nguyen C, Solon M, BarczakAJ, Zlock LT, Blagev DP, Finkbeiner WE, Ansel KM, Arron JR, Erie DJ, Woodruff PG: Airway epithelial mirna expression is altered in asthma. Am J Respir Crit Care Med 2012;186:965-974.
69. Plank M, Maltby S, Mattes J, Foster PS: Targeting translational control as a novel way to treat inflammatory disease: The emerging role of micrornas. Clin Exp Allergy 2013;4 3:981-999.
70. Lino Cardenas CL, Kaminski N, Kass DJ: Micromanaging micrornas: Using murine models to study micrornas inlungfibrosis. DrugDiscoveryToday: Disease Models doi.org/10.1016/j.ddmod.2012.11.003.
71. Caruso P, MacLean MR, Khanin R, McClure J, Soon E, Southgate M, MacDonald RA, Greig JA, Robertson KE, Masson R, Denby L, Dempsie Y, Long L, Morrell NW, BakerAH: Dynamic changes in lung micro rna profiles during the development of pulmonary hypertension due to chronic hypoxia and monocrotaline. Arterioscl Thrombo Vase Biol 2010;30:716-723.
72. CourboulinA, Paulin R, Giguere NJ, Saksouk N, PerreaultT , Meloche J, Paquet ER, Biardel S, Provencher S, Cote J, Simard MJ, Bonnet S: Role for mir-204 in human pulmonary arterial hypertension. J Exp Med 2011;208:535-548.
73. White K, Loscalzo J, Chan SY: Holding our breath: The emerging and anticipated roles of microrna in pulmonaryhypertension. PulmonCirc 2012;2:278-290.
74. Cho JH, Gelinas R, Wang K, Etheridge A, Piper MG, Batte K, Dakhallah D, Price J, Bornman D, Zhang S, Marsh C, Galas D: Systems biology of interstitial lung diseases: Integration of mrna and microrna expression changes. BMC Med Genomics 2011;4:8.
75. We ng C-W, Lee S-C, Lee Y-L, Ng K-L: Analysis of the nci-60 dataset for cancer-related microrna and mrna using expression profiles. Comput Biol Chem 2013;44:15-21.
76. Cascione L, Gasparini P, Lovat F , Carasi S, Pulvirenti A, Ferro A, Alder H, He G, Vecchione A, Croce CM, Shapiro CL, Huebner K: Integrated microrna and mrna signatures associated with survival intriple negative breast cancer. PLoS One 2 013;8:e55910.
77. Bhattacharya S, Mariani TJ: Systems biologyapproaches to identify developmental bases for lung diseases. Pediatr Res 2013;73:514-522.
78. Agusti A, Sobradillo P, Ce lli B: Addressing the complexity of chronic obstructive pulmonary disease: From phenotypes and biomarkers to scale-free networks, systems biology, and p4 medicine. Am J Respir Crit Care Med 2011;183:1129-1137.
79. Sil verman EK, Loscalzo J: Network medicine approaches to the genetics of complex diseases. Discov Med 2012;14:143-152.
80. Betel D, Wilson M, Gabow A, Marks DS, Sander C: The microrna.Org resource: Targets and expression. Nucleic Acids Res 2008;36:D149-153.
81. Griffiths-Jones S, Saini HK, Van Dongen S, Enright AJ: Mirbase: Tools for microrna genomics. Nucleic Acids Res2008;36:D154-158.
82. Le wis BP Burge CB Bartel DP Conserved seed pairing, often flanked by adenosines, indicates that thousands ofhuman genes are microrna targets Cell 2005 120 15-20. (Pubitemid 40094598)
83. Grimson A, Farh KKH, Johnston WK, Garrett-Engele P, Lim LP, Bartel DP: Microrna targeting specificity in mammals: Determinants beyond seed pairing. Mol Cell 2007;27:91-105. (Pubitemid 46991392)
84. Friedman RC, Farh KK-H, Burge CB, Bartel DP: Most mammalian mrnas are conserved targets of micrornas. Genome Res 2009;19:92-105.
85. Maragkakis M, Reczko M, Simossis VA, Alexiou P, Papadopoulos GL, Dalamagas T, Giannopoulos G, Goumas G, Koukis E, Kourtis K, Vergoulis T, Koziris N, Sellis T, Tsanakas P, Hatzigeorgiou AG: Diana-microt web server: Elucidatingmicrornafunctionsthroughtargetprediction. Nucleic Acids Res 2009;37:W273-276.
86. Krek A, Grun D, Poy MN, Wolf R, Rosenberg L, Epstein EJ, MacMenamin P, da Piedade I, Gunsalus KC, Stoffel M, RajewskyN: Combinatorial microrna target predictions. Nature Genet 2005;37:495-500. (Pubitemid 40617277)
87. Papadopoulos GL, Reczko M, Simossis VA, Sethupathy P, Hatzigeorgiou AG: T he database of experimentally supported targets: A functional update oftarbase. Nucleic Acids Res 2009;37:D155-158.
88. Xiao F, Zuo Z, Cai G, Kang S, Gao X,LiT: Mirecords: An integrated resource for microrna-target interactions. Nucleic Acids Res 2009;37:D105-110.
89. Hsu SD, Lin FM, Wu WY, Liang C, Hua ng WC, Chan WL, Tsai WT, Chen GZ, Lee CJ, Chiu CM, Chien CH, Wu MC, Huang CY, Tsou AP, Huang HD: Mirtarbase: A database curates experimentally validated microrna-target interactions. Nucleic Acids Res 2011;39:D163-169.
90. Dweep H, Sticht C, Pandey P, Gretz N: Mirwalk-database: Prediction of possible mirna binding sites by " walking" the genes of three genomes. J Biomed Inform 2011;44:839-847.
91. Hsu PW, Huang HD, Hsu SD, Lin LZ, Tsou AP, Tseng CP, Stadler PF, Washietl S, Hofacker IL: Mirnamap: Genomic maps of microrna genes and their target genes in mammalian genomes. Nucleic Acids Res 200 6;34:D135-139.
92. Huang JC, Babak T, Corson TW, Chua G, Khan S, Gallie BL, Hughes TR, Blencowe BJ, Frey BJ, Morris QD: Using expression profiling data to identifyhuman microrna targets. Nat Me thods 2007;4:1045-1049. (Pubitemid 350201777)
93. Sales G, Coppe A, Bisognin A, Biasiolo M, Bortoluzzi S, Romualdi C: Magia, a web-based tool for mirna and genes integrated analysis. Nucleic Acids Res 2010;38:W352-359.
94. Elkan-Miller T, Ulitsky I, Hertzano R, Rudnicki A, Dror AA, Lenz DR, Elkon R, Irmler M, Beckers J, Shamir R, Avraham KB: Integration oftranscriptomics, proteomics, and microrna analyse s reveals novel microrna regulation of targets in the mammalian inner ear. PLoS One 2011;6:el8195.
95. Beck D, Ayers S, Wen J, Brandi MB, Pham TD, Webb P, Chang CC, Zhou X: Integrative analysis of next generation sequencing for small non-coding rnas and transcriptional regulation in myelodysplastic syndromes. BMC Med Genomics 2011;4:19.
96. Muniategui A, Pey J, Planes FJ, Rubio A: Joint analysis of mirna and mrna expression data. Brief Bioinform 2013;14:263-278.
97. Shankavaram UT, Varma S, Kane D, Sunshine M, Chary KK, Reinhold WC, Pommier Y, Weinstein JN: Cellminer: A relational database and querytool forthe nci-60 cancer cell lines. BMC Genomics 2009;10:277.
98. Jalali S, Bhartiya D, Lalwani MK, Sivasubbu S, Scaria V: Systematic transcriptome wide analysis of lncrna-mirna interactions. PLoS One 2013;8:e53823.
99. Flintoft L: Non-coding rna: Structure and function for lncrnas. Nature reviews Genetics 2013;14:598.
100. Enfield KSS, Pikor LA, Martinez VD, Lam WL: Mechanistic roles of noncoding rnas in lung cancer biology and their clinical implications. Genet Res Int 2012;2012:16.
101. YangX, Gao L, Guo X, ShiX, Wu H, Song F, Wang B: A network based method for analysis oflncrna-disease associations and prediction oflncrnas implicated in diseases. PLoS One 2014;9:e87797.
102. Liu M-X, ChenX, Chen G, Cui Q-H, Yan G-Y: A computational frameworkto infer human disease-associated long noncoding rnas. PLoS One 2014;9:e84408.
103. Wang Z Gerstein M Snyder M Rna-seq: A revolutionarytool for transcriptomics Nat Rev Genet 2009 10 57-63.
104. Beyond the genome 2012 boston, ma, USA. 27-29 September 2012. Abstracts. BMC Proc 2012;6:01-P54.
105. Beane J, VickJ, Schembri F, Anderlind C, GowerA, Ca mpbell J, Luo L, ZhangXH, Xiao J, AlekseyevYO, Wang S, Levy S, Massion PP, Lenburg M, Spira A: Characterizing the impact of smoking and lung cancer on the airway transcriptome using rna-seq. Cancer Prev Res (PhilaJ 20 11;4:803-817.
106. Hackett NR, Butler MW, Shaykhiev R, Salit J, Omberg L, Rodriguez-Flores JL, Mezey JG, Strulovici-Barel Y, Wang G, Didon L, Crystal RG: Rna-seq quantification of the human small airway epithelium transcriptome. BMC Ge nomics 2012;13
107. Zhou C, Chen H, Han L, Xue F, Wang A, Liang Y-j: Screening of genes related to lung cancer caused by smoking with rna-seq. Eur Rev Med Pharmacol Sci 2014;18:117-125.
108. Yick CY, Zwinderman AH, Kunst PW, Grunberg K, Mauad T, Dijkhuis A, Bel EH, Baas F, Lutter R, Sterk PJ: Transcriptome sequencing (rna-seq) ofhuman endobronchial biopsies: Asthma versus controls. The European respiratoryjournal 2013;42:662-670.
109. Robinson MD, McCarthy DJ, Smyth GK: Edger: A bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics 2010;26:139-140.
110. Goncalves A, Tikhonov A, Brazma A, Kapushesky M: A pipeline for rna-seq data processing and quality assessment. Bioinformatics 2011;27:867-869.
111. Li H, Ha ndsaker B, Wysoker A, Fennell T, Ruan J, Homer N, Marth G, Abecasis G, Durbin R: The sequence alignment/map formatand samtools. Bioinformatics 2009;25:2078-2079.
112. Flicek P, Amode MR, Barrell D, Beal K, Brent S, Carvalho-Silva D, Clapham P, Coates G, Fairley S, Fitzgerald S, Gil L, Gordon L, Hendrix M, Hourlier T, et al.: Ensembl 2012. Nucleic Acids Res 2012;40:D 84-90.
113. Yang IV: Epigenomics of idiopathic pulmonary fibrosis. Epigenomics 2012;4:195-203.
114. Adcock IM, Ford P, Ito K, Barnes PJ: Epigenetics and airways disease. Respiratory Res2006;7:21.
115. Handel AE, Ebers GC, Ramagopalan SV: Epigenetics: Molecular mechanisms and implications for disease. Trends Mol Med 2010;16:7-16.
116. Martino D, Prescott S: Epigenetics and prenatal influences on asthma and allergic airways disease. Chest 2011;139:640-647.
117. Schwartz DA: Epigenetics and environmental lung disease. Proc Am Thorac Soc 2010;7:123-125.
118. Sundar IK, Yao H, Rahman I: Oxidative stress and chromatin remodeling in chronic obstructive pulmonary disease and smoking-related diseases. Antioxid Redox Signal 2013;18:1956-1971.
119. Rosas 10, Yang IV: The promise of epigenetic therapies in treatment of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2013;187:336-338.
120. Vucic EA, Chari R, Thu KL, Wilson IM, Cotton AM, Kennett JY, Zh ang M, Lonergan KM, Steiling K, Brown CJ, McWilliams A, Ohtani K, Lenburg ME, Sin DD, Spira A, MacAulay CE, Lam S, Lam WL: DNA methylation is globally disrupted and associated with expression changes in cop d small airways. Am J Respir Cell Mol Biol 2013;10.1165/rcmb.2013-03040C
121. Sanders YY, Ambalavanan N, Halloran B, ZhangX, Liu H, Crossman DK, Bray M, Zhang K, ThannickalVJ, Hagood JS: Altered DNA methylati on profile in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2012;186:525-535.
122. Rabinovich El, Kapetanaki MG, Steinfeld I, Gibson KF, Pandit KV, Yu G, Yakhini Z, Kaminski N: Global methylation patterns in idiopathic pulmonary fibrosis. PLoS 0ne2012;7:e33770.
123. Pandit KV, Milosevic J, Kaminski N: Micrornas in idiopathic pulmonary fibrosis. Transl Res 2011;157:191-199.
124. Dakhlallah D, Batte K, Wang Y, Cantemir-Stone CZ, Yan P, Nuovo G, Mikhail A, Hitchcock CL, Wright VP, Nana-Sinkam SP, Piper MG, Marsh CB: Epigenetic regulation of mir-17~92 contributes to the patho genesis of pulmonary fibrosis. Am J Respir Crit Care Med 2013;187:397-405.
125. Balgkouranidou I Liloglou T Lianidou ES Lung cancer epigenetics: Emerging biomarkers Biomark Med 2013 7 49-58.
126. Huang SK, Scruggs AM, Donaghy J, Horowitz JC, Zaslona Z, Przybranowski S, White ES, Peters-Golden M: Histone modifications are responsible for decreased fas expression and apoptosis resistance in fibr otic lung fibroblasts. Cell Death Dis 2013;4:e621.
127. Sundar IK, Nevid MZ, FriedmanAE, Rahman I: Cigarette smoke induces distincthistone modifications in lung cells: Implications for the pathogenesis of copd and lung cancer. J Proteome Res 2013;13:982-996.
128. Liu Y, Li H, Xiao T, Lu Q: Epigenetics in immune-mediated pulmonary diseases. Clinic RevAllerg Immunol 2013;45:314-330.
129. Weber M, Davies JJ, Wittig D, Oakeley EJ, Haase M, Lam WL, Schubeler D: Chromosome-wide and promoter-specific analyses identify sites of differential DNA methylation in normal and transformed human cells. Nature Genet 2005;37:853-862. (Pubitemid 41077111)
130. Frommer M, McDonald LE, Millar DS, Collis CM, Watt F, Grigg GW, Molloy PL, Paul CL: A genomic sequencing protocol thatyields a positive display of 5-methylcytosine residues in individual DNA strands. Proc Natl Acad SciUSA 1992;89: 1827-1831.
131. Krueger F, Andrews SR: Bismark: A flexible aligner and methylation caller for bisulfite-seq applications. Bioinformatics 2011;27:1571-1572.
132. Milne I, Bayer M, Cardie L, Sha w P, Stephen G, Wright F, Marshall D: Tablet-next generation sequence assembly visualization. Bioinformatics 2010;26:401-402.
133. Fingerman IM, Zhang X, RatzatW, Husain N, Cohen RF, Schuler GD: Ncbi epigenomics: What's new for 2013. Nucl Acids Res 2013;41:D221-225.
134. Fingerman IM, McDaniel L, Zhang X, Ratzat W, Hassan T, Jiang Z, Cohen RF, Schuler GD: Ncbi epigenomics: A ne w public resource for exploring epigenomic data sets. Nucl Acids Res 2011;39:D908-912.
135. Hirsch J, Hansen KC, Burlingame AL, Matthay MA: Proteomics: Currenttechniques and potential applications to lung disease. Am J Physiol Lung Cell Mol Physiol 2004;287:Ll-23.
136. Wattiez R, Falmagne P: Proteomics ofbronchoalveolar lavage fluid. J Chromatogr B Analyt Technol Biomed Life Sci 2005;815:169-178.
137. Bowler RP, Ellison MC, Reisdorph N: Proteomics in pulmonary medicine. Chest 2006;130:567-574. (Pubitemid 44267028)
138. Wiktorowicz J, Jamaluddin M: Proteomic analysis ofthe asthmatic airway; in BrasierAR (ed): Heterogeneity in asthma. Springer USA, 2014, vol 795, pp 221-232.
139. Xu D-D, Deng D-F, Li X, Wei L-L, Li Y-Y, Yang X-Y, Yu W, Wang C, Jiang T-T, Li Z-J, Chen Z-L, Zhang X, Liu J-Y, Ping Z-P, Qiu Y-Q, Li J-C: Discovery and identification of serum potential biomarkers for pulmonary tuberculosis using itraq-coupled two-dimensional lc-ms/ms. Proteomics 2014;14:322-331.
140. Konsavage WM, Umstead TM, Wu Y, Phelps DS, Shenberger JS: Hyperoxia-induced alterations in the pulmonaryproteome ofjuvenile rats. Exp Lung Res 2013;39:107-117.
141. Giorgianni F, Mileo V, Desiderio DM, Catinella S, Beranova-Giorgianni S: Characterization ofthe phosphoproteome in humanbronchoalveolar lavage fluid. IntJ Proteomics 2012;2012:460261.
142. Nguy en EV, Gharib SA, Palazzo SJ, ChowYH, Goodlett DR, Schnapp LM: Proteomic profiling of bronchoalveolar lavage fluid in critically ill patients with ventilator-associated pneumonia. PLoS One 2013;8:e58782.
143. Landi C, Bargagli E, Bianchi L, Gagliardi A, Carleo A, Bennett D, Perari MG, Armini A, Prasse A, Rottoli P, Bini L: Towards a functional proteomics approach to the comprehension of idiopathic pulmonary fi brosis, sarcoidosis, systemic sclerosis and pulmonarylangerhans cell histiocytosis. J Proteomics 2013;83:60-75.
144. Wang YT, Tsai CF, Hong TC, Tsou CC, Lin PY, Pan SH, Hong TM, Yang PC, Sung TY, Hsu WL, Chen YJ: An informatics-assisted label-free quantitation strategythat depicts phosphoproteomic profiles in lung cancer cell invasion. J Proteome Res 2010;9:5582-5597.
145. Lopez E, Cho WC: Phosphoproteomics and lung cancer research. Int J Mol Sci 2012;13:12287-12314.
146. Sudhir PR Hsu CL Wang MJ WangYT Chen YJ Sung TY Hsu WL YangUC Chen JYPhosphoproteomics identifies o ncogenic ras signaling targets and their involvement in lung adenocarcinomas PLoS One 2011 6 e20199.
147. Park JO, Choi DY, Choi DS, Kim HJ, Kang JW, Jung JH, Lee JH, Kim J, Freeman MR , Lee KY, Gho YS, Kim KP: Identification and characterization of proteins isolated from microvesicles derived from human lung cancer pleural effusions. Proteomics 2013;13:2125-2134.
148. Pastor MD, Nogal A, Molina-P inelo S, Carnero A, Paz-Ares L: Proteomic biomarkers in lung cancer. Clin Transl Oncol 2013;15:671-682.
149. Krueger KE, Srivastava S: Posttranslational protein modifications: Current implications for cancer detection, prevention, and therapeutics. Mol Cell Proteom 2006;5:1799-1810. (Pubitemid 44688189)
150. Vaudel M, Sickmann A, Martens L: Introduction to opportunities and pitfalls in functional mass spectrometry based proteomics. Biochim Biophys Acta 2014;1844:12-20.
151. Perez-Riverol Y, Hermjakob H, Kohlbacher 0, Martens L, Creasy D, Cox J, Leprevost F, Shan BP, Perez-Nueno VI, Blazejczyk M, Punta M, Vierlinger K, Valiente PA, Leon K, Chinea G, Guirol a 0, Bringas R, Cabrera G, Guillen G, Padron G, Gonzalez LJ, Besada V: Computational proteomics pitfalls and challenges: Havanabioinfo 2012 workshop report. J Proteomics 2013;87:134-138.
152. Sigrist CJ, De Castro E, Cerutti L, Cuche BA, Hulo N, Bridge A, Bougueleret L, Xenarios I: New and continuing developments at prosite. Nucl Acid Res 2013;41:D344-347.
153. Kiefer F, Arnold K, Kunzli M, Bordoli L, Schwede T: The swiss-model repositoryand associated resources. Nucl Acid Res 2009;37:D387-392.
154. Wilkins MR, Gasteiger E, Bairoch A, Sanchez JC, Williams KL, Appel RD, Hochstrasser DF: Protei n identification and analysis tools inthe expasy server. Methods Mol Biol 1999;112:531-552.
155. Wilkins MR, Gasteiger E, Sanchez JC, Appel RD, Hochstrasser DF: Protein identification with sequence tags. Curr Biol 1996;6:1543-1544. (Pubitemid 27050211)
156. Wilkins MR, Gasteiger E, Tonella L, Ou K, Tyler M, Sanchez JC, Gooley AA, Walsh BJ, Bairoch A, Appel RD, Williams KL, Hochstrasser DF: Protein identification with n and c-terminal sequence tags in proteome projects. J Mol Biol 1998;278:599-608. (Pubitemid 28224857)
157. Wilkins MR, Pasquali C, Appel RD, Ou K, Golaz 0, Sanchez JC, Yan JX, Gooley AA, Hughes G, Humphery-Smith I, Williams KL, Hochstrasser DF: From proteins to proteomes: Large scale protein identification bytwodimensional electrophoresis and amino acid analysis. Biotechnology (NY) 1996;14:61-65.
158. Wilkins MR, Ou K, Appel RD, Sanchez J-C, Yan JX, Golaz 0, Farnsworth V, Cartier P, Hochstrasser DF, Williams KL, Gooley AA: Rapid protein identification using n-terminal "sequence tag" and amino acid analysis. Biochem Biophys Res Com 1996;221:609-613.
159. Pappin DJ, Hojrup P, BleasbyAJ: Rapid identification of proteins by peptide-mass fingerprinting. Curr Biol 1993;3:327-332.
160. ZhangW, Chait BT: Profound: An expert system for protein identification using mass spectrometric peptide mapping information. Anal Chem 2000;72:2482-2489. (Pubitemid 30395651)
161. Eng J, McCormackA, Yates J: An approach to correlate tandem mass spectral data of peptides with amino acid sequences in a protein database. J Am Soc Mass Spectrom 1994;5:976-989.
162. Perkins DN, Pappin DJ, Creasy DM, Cottrell JS: Probability-based protein identification by searching sequence databases using mass spectrometry data. Electrophoresis 1999;20:3551-3567. (Pubitemid 30007252)
163. Geer LY, Markey SP, Kowalak JA, Wagner L, Xu M, Maynard DM, Yang X, Shi W, Bryant SH:0pen mass spectrometry search algorithm. J Proteome Res 2004;3:958-964. (Pubitemid 39425651)
164. Balgley BM, Laudeman T, Yang L, Song T, Lee CS: Comparative evaluation of tandem ms search algorithms using a target-decoy search strategy. Mol Cell Proteomics 2007;6:1599-1608. (Pubitemid 47506170)
165. Wenger CD, Phanstiel DH, Lee MV, Bailey DJ, Coon JJ: Compass: A suite of pre-and post-search proteomics software tools for omssa. Proteomics 2011;11:1064-1074.
166. Deutsch EW, Lam H, Aebersold R: Peptideatlas: A resource for target selection for emerging targeted proteomics workflows. EMBO Rep 2008;9:429-434. (Pubitemid 351627279)
167. Craig R Cortens JP Beavis RC Open source system for analyzing, validating, and storing protein identification data J Proteome Res 2004 3 1234-1242. (Pubitemid 40040378)
168. Schaab C, Geiger T, Stoehr G, Cox J, Mann M: Analysis of high accuracy, quantitative proteomics data in the maxqb database. Mol Cell Proteomics 2012;11:M111 014068.
169. Mead JA, Bianco L, Bessant C: Recent developments in public proteomic ms repositories and pipelines. Proteomics 2009;9:861-881.
170. Vizcaino JA, Cote RG, Csordas A, Dianes JA, FabregatA , FosterJM, Griss J, Alpi E, Birim M, Contell J, O'Kelly 5, SchoeneggerA, Ovelleiro D, Perez-RiverolY, ReisingerF, Rios D,WangR, Hermjakob H: The proteomics identifications (pride) database and associated tools: Status in2013. Nu cleic Acids Res 2013;41:D1063-1069.
171. Jones P, Martens L: Usingthe pride proteomics identifications database for knowledge discovery and data analysis. Methods Mol Biol 2010;604:297-307.
172. Jones P, Cote R: The pride proteomics identifications database: Data submission, query, and dataset comparison. Methods Mol Biol 2008;484:287-303.
173. Martens L, Hermjakob H, Jones P, Adamski M , Taylor C, States D, Gevaert K, Vandekerckhove J, Apweiler R: Pride: The proteomics identifications database. Proteomics 2005;5:3537-3545. (Pubitemid 41192059)
174. Kolker E, Higdon R, Haynes W, Welch D, Broomall W, Lancet D, Stanberry L, Kolker N: Moped: Model organism protein expression database. Nucleic Acids Res 2012;40:D1093-1099.
175. Wang M, Weiss M, Simonovic M, Haertinger G, Schrimpf SP , Hengartner MO, Von Mering C: Paxdb, a database of protein abundance averages across all three domains oflife. Mol Cell Proteomics 2012;11:492-500.
176. Horai H, Arita M, Kanaya S, Nihei Y, Ike da T, Suwa K, Ojima Y, Tanaka K, Tanaka S, Aoshima K, Oda Y, Kakazu Y, Kusano M, Tohge T, Matsuda F, Sawada Y, Hirai MY, Nakanishi H, Ikeda K, Akimoto N, Maoka T, Takahashi 6, Ara T, Sak u rai N, Suzuki H, Shibata D, Neumann S, Iida T, Funatsu K, Matsuura F, Soga T, Taguchi R, Saito K, Nishioka T: Massbank: A public repository for sharing mass spectral data for life sciences. J Mass Spectromet 2010;45:703-714.
177. Gaudet P, Argoud-Puy G, Cusin I, Duek P, Evalet 0, Gateau A, Gleizes A, Pereira M, Zahn-Zabal M, Zwahlen C, Bairoch A, Lane L: Nextprot: Organizing protein knowledge in the context ofhuman proteome projects. J Proteome Res 2013;12:293-298.
178. Lane L,Argoud-Puy G, BritanA, CusinI, DuekPD, EvaletO, GateauA, GaudetP, GleizesA, Masselot A, Zwahlen C, Bairoch A: Nextprot: A knowledge platform for human proteins. Nucleic Acids Res 2012;40:D76-83.
179. Method ofthe year 2012. Nat Meth 2013;10:1-1.
180. Doerr A: Targeted proteomics. Nat Meth 2011;8:43-43.
181. Doerr A: Mass sp ectrometry-based targeted proteomics. Nat Meth 2013;10:23-23
182. Gillet LC, Navarro P, Tate S, Rost H, Selevsek N, Reiter L, Bonner R, Aebersold R: Targeted data extraction of the ms/ms spe ctra generated by data-independent acquisition: A new conceptfor consistent and accurate proteome analysis. Mol Cell Proteom 2012;11:0111.016717.
183. Savaryn JP, Catherman AD, Thomas PM, Abecassis MM, Kelleher NL: The emergence of top-down proteomics in clinical research. Genome Med 2013;5:1-8.
184. Yassine H, Borges CR, Schaab MR, Billheimer D, Stump C, Reaven P, Lau SS, Nelson R: Mass spectrometric immunoassay and multiple reaction monitoring as targeted ms-based quantitative approaches in biomarker development: Potential applications to cardiovascular dise ase and diabetes. Proteomics Clin Appl. 2013;7:528-540.
185. Krastins B, Prakash A, Sarracino DA, Nedelkov D, Niederkofler EE, Kiernan UA, Nelson R, Vogelsang MS, Vadali G, Garces A: Rapid development of sensitive, high-throughput, quantitative and highly selective mass spectrometric targeted immunoassays for clinically important proteins in human plasma and serum. Clin Biochem 2013;46:399-410.
186. Kim HK, Choi YH, Erkelens C, Lefeber AW, Verpoorte R: Metabolic fingerprinting of ephedra species using lh-nmr spectroscopy and principal component analysis. Chem Pharm Bull (Tokyo) 2005;53:105-109. (Pubitemid 40879848)
187. Ch oi HK, Choi YH, Verberne M, Lefeber AW, Erkelens C, Verpoorte R: Metabolic fingerprinting of wild type and transgenic tobacco plants by lh nmr and multivariate analysis technique. Phytochemistry 2004;65:857-86 4. (Pubitemid 38471762)
188. Johnson HE, Broadhurst D, Kell DB, Theodorou MK, Merry RJ, Griffith GW: High-throughput metabolic fingerprinting of legume silage fermentations via fourier transform infrared spectroscopy and chemometrics. Ap pl Environ Microbiol 2004;70:1583-1592. (Pubitemid 38372074)
189. Gidman E Goodacre R Emmett B Smith AR Gwynn-Jones D: Investigating plant-plant interference by metabolic fingerprinting. Phytochemistry2003 63; 705-710. (Pubitemid 36818553)
190. Allen J, Davey HM, Broadhurst D, Heald JK, Rowland JJ, Oliver SG, Kell DB: High-throughput classification of yeast mutants for functional genomics using metabolic footprinting. Nat Biotechnol 2003; 21:692-696. (Pubitemid 36638098)
191. Serkova NJ, Van Rheen Z, Tobias M, Pitzer JE, Wilkinson JE, Stringer KA: Utility of magnetic resonance imaging and nuclear magnetic resonance-based metabolomics for quantification of inflammatory lung injury. Am J Physiol Lung Cell Mol Physiol 2008;295:L152-161.
192. Wishart DS: Quantitative metabolomics using nmr. TrAC Trends inAnalytical Chemistry 2008;27:228-237.
193. Oliver SG, W inson MK, Kell DB, Baganz F: Systematic functional analysis of the yeast genome. Trends Biotechnol 1998;16:373-378. (Pubitemid 28410425)
194. Nicholson JK, Lindon JC, Holmes E: ' Metabonomics': Understandingthe meta bolic responses ofliving systems to pathophysiological stimuli via multivariate statistical analysis of biological nmr spectroscopic data. Xenobiotica 1999;29:1181-1189.
195. Wen T, Gao L, Wen Z, Wu C, Tan CS, Toh WZ, Ong CN: Exploratory investigation of plasma metabolomics in human lung adenocarcinoma. Mol BioS yst2013;9:2370-2378.
196. Weckwerth W: Metabolomics in systems biology. Annu Rev Plant Biol 2003;54:669-689. (Pubitemid 37400009)
197. Raamsdonk LM, Teusink B, Broadhurst D, Zhang NS, Hayes A, Walsh MC, Berden J A, Brindle KM, Kell DB, Rowland JJ, Westerhoff HV, Van Dam K, Oliver SG:A functional genomics strategy that uses metabolome datato revealthe phenotype of silentmutations. NatBiotechnol 2001;19:45-50. (Pubitemid 32051955)
198. Carraro S, Rezzi S, Reniero F, Heberger K, Giordano G, Zanconato S, Guillou C, Baraldi E: Metabolomics applied to exhaled breath condensate in childhood asthma. Am J Respir Crit Care Med 2007;175:986-990. (Pubitemid 46741749)
199. De Laurentiis G, Paris D, Melck D, Maniscalco M, Marsico S, Corso G, Motta A, Sofia M: Metabonomic analysis of exhaled breath condensate in adults by nuclear magnetic resonance spectroscopy. Eur Respir J 2008;32:1175-1183.
200. Naz S, Garcia A, Rusak M, Barbas C: Method development and validation for rat serum fingerprinting with ce-ms: Applicationto ventilator-induced-lung- injury study. Anal Bioanal Chem 2013;405:4849-4858.
201. Emwas A-H, Salek R, Griffin J, MerzabanJ: Nmr-based metabolomics in human disease diagnosis: Applications, limitations, and recommendations. Metabolomics 2013;9:1048-1072.
202. Carraro S, Giordano G, Reniero F, Carpi D, Stocchero M, Sterk PJ, Baraldi E: Asthma severity in childhood and metabolomic profiling ofbreath condensate. Allergy 2013;68:110-117.
203. Jung J, Kim SH, Lee HS, Choi GS, JungYS, Ryu DH, Park HS, Hwang GS: Serum metabolomics reveals pathways and biomarkers associated with asthma pathogenesis. Clin Exp Allergy 2013;43:42 5-433.
204. Ried JS, Baurecht H, Stuckler F, Krumsiek J, Gieger C, Heinrich J, Kabesch M, Prehn C, Peters A, Rodriguez E, Schulz H, Strauch K, Suhre K, Wang-Sattler R, Wichmann HE, Thei s FJ, Illig T, Adamski J, Weidinger S: Integrative genetic and metabolite profiling analysis suggests altered phosphatidylcholine metabolism in asthma. Allergy 2013;68:629-636.
205. Chen J, Ma M, Sh en N, Xi JJ, Tian W: Integration of cancer gene co-expression network and metabolic networkto uncoverpotential cancer drugtargets. J Proteome Res 2013;12:2354-2364.
206. Mehrotra B, Mendes P: Bioinform atics approaches to integrate metabolomics and other systems biology data; in Saito K, Dixon R, Willmitzer L (edsj: Plant metabolomics. Springer Berlin Heidelberg, 2006, vol 57, pp 105-115.
207. ShulaevV: Metabolomicstechnologya ndbioinformatics. BriefBioinformat2006; 7:128-139.
208. Stein SE: An integrated method for spectrum extraction and compound identification from gas chromatography/mass spectrometry data. J Am Soc Mass Spectrom 1999;10:770-781. (Pubitemid 34506228)
209. Pluskal T, Castillo S, Villar-Briones A, Oresic M: Mzmine 2: Modular framework for processing, visualizing, and analyzing mass spectrometry-based molecular profile data. BMC Bioinformatics 2010; 11:395.
210. Neuweger H Albaum SP Dondrup M Persicke M Watt T Niehaus K Stoye J GoesmannA: Meltdb: A software platform forthe analysis and integration of metabolomics experiment data Bioinfor matics 2008 24 2726-2732. (Pubitemid 352722615)
211. Xia J, Mandal R, Sinelnikov IV, Broadhurst D, Wishart DS: Metaboanalyst 2.0-A comprehensive server for metabolomic data analysis. Nucleic Acids Res 2012;40:W127-133.
212. Smith CA, Want EJ, O'Maille G, Abagyan R, Siuzdak G: Xcms: Processing mass spectrometry data for metabolite profiling using nonlinear peak alignment, matching, and identification. Anal Chem 2006;78:779-787 . (Pubitemid 43228585)
213. Wishart DS, Jewison T, Guo AC, Wilson M, Knox C, Liu Y, Djoumbou Y, Mandal R, Aziat F, Dong E, Bouatra S, Sinelnikov I, Arndt D, Xia J, Liu P, Yallou F, Bjorndahl T, Pere z-Pineiro R, Eisner R, Allen F, Neveu V, Greiner R, ScalbertA: Hmdb 3.0-The human metabolome database in 2013. Nucleic Acids Res 2013;41:D801-807.
214. Wishart DS, Tzur D, Knox C, Eisner R, Guo AC, Young N, Cheng D, Jewell K, Arndt D, Sawhney S, Fung C, Nikolai L, Lewis M, Coutouly MA, Forsythe I, Tang P, Shrivastava S, Jeroncic K, Stothard P, Amegbey G, Block D, Hau DD, Wagner J, Miniaci J, Clements M, Gebremedhin M, Guo N, Zhang Y, Duggan GE, Macinnis GD, Weljie AM, Dowlatabadi R, Bamforth F, Clive D, Greiner R, Li L, Marrie T, Sykes BD, Vogel HJ, Quere ngesser L: Hmdb: The human metabolome database. Nucleic Acids Res 2007;35:D521-526.
215. Wishart DS, Knox C, Guo AC, Eisner R, Young N, Gautam B, Hau DD, Psychogios N, Dong E, Bouatra S, Mandal R, Sinelnikov I, Xia J, Jia L, Cruz JA, Lim E, Sobsey CA, Shrivastava S, Huang P, Liu P, Fang L, Peng J, Fradette R, Cheng D, Tzur D, Clements M, Lewis A,De Souza A, Zuniga A, D awe M, Xiong Y, Clive D, Greiner R, Nazyrova A, Shaykhutdinov R, Li L, Vogel HJ, Forsythe I: Hmdb: A knowledgebase for the human metabolome. Nucleic Acids Res 2009;37:D603-610.
216. Hood L: Systems biology and p4 medicine: Past, present, and future. Rambam Maimonides Med J 2013;4:e0012.